Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer


NCT01718873

Interventional

Phase 3

Unknown status
OBELICS
The purpose of this study is to evaluate if giving bevacizumab prior to chemotherapy compared to giving bevacizumab at the same time as chemotherapy improves patient overall response to treatment.
May 31,2012
All
18 Years
75 Years
230

In order to facilitate the use of our website, we use cookies.

Please confirm if you accept our tracking cookies. When declining the cookies, you can continue visiting the website without sending data to third party services. Read our complete cookie statement here.